G1GLP1 Note Country Australia

HomeCoverageWegovyAustralia

CoverageAustralia · Checked · Rechecked monthly

Wegovy on the PBS: Is It Listed and What It Costs in Australia

As of 20 November 2026, Wegovy is not on the PBS for weight loss, so you pay the private price: A$249 to A$389 for one pen, which is four weeks of doses. The PBAC recommended a listing for people with obesity and established cardiovascular disease in November 2025, but the listing has not happened yet.

Is Wegovy on the PBS?

No. Wegovy for weight loss is not subsidised by the PBS.

PBAC adviceRecommended, Nov 2025, for obesity with established cardiovascular disease

PBS listingHas not yet occurred

Private price per penA$249 – A$389

If it is listed, general patients pay up toA$25 per script

Based on the PBS medicine status page and the PBAC outcome. This page is updated when a listing happens.

What you pay now depends on your dose.

See the price of each Wegovy dose in Australia

The price steps up with the dose, to $389 from 1.7 mg.

PBS statusListing dateMedicarePricePBS chargesNovoCareStepsFAQ

Wegovy PBS

The Pharmaceutical Benefits Scheme (PBS) is how the Australian Government pays for most of the cost of a medicine. A medicine has to be listed before you pay only the set patient charge.

Wegovy for weight loss is not on the PBS. No drug has been listed on the PBS as a treatment for obesity alone.

Mounjaro has its own page: Mounjaro on the PBS.

The closest listed drug is Ozempic. It has the same active ingredient, but the PBS subsidises it for type 2 diabetes only.

When will Wegovy be listed on the PBS

The PBAC met on 5 November 2025 and recommended Wegovy for people with obesity and established cardiovascular disease.

The advice came with two conditions: a price reduction and a risk-sharing arrangement. The PBAC's summary letter to the Minister is dated 15 December 2025 and the outcome was published on 19 December 2025.

Wegovy PBS progress, from the PBS medicine status page (current at 1 November 2026)

PBAC meeting5 November 2025

PBAC outcomeRecommended

Agreement on listing termsHas not yet commenced

Government processesHas not yet commenced

PBS listingHas not yet occurred

The PBS says a listing usually takes about five months from the sponsor's submission, and sometimes longer. Wegovy is past that mark.

No listing date has been announced. Do not plan around a PBS price until the date is official.

Even after a listing, it would not reach everyone. The recommendation covers people with obesity who already have cardiovascular disease.

Wegovy Medicare

Your Medicare card does not reduce the price of Wegovy for weight loss. The reason is that Wegovy is not on the PBS.

Medicare can still apply to the doctor visit where you get the prescription. It does not apply to the cost of the pen.

If a listing happens, you would get Wegovy on a PBS prescription and the patient charges below would apply.

Wegovy price in Australia

With no PBS price, each pharmacy sets its own. A public price list for online prescription uploads in November 2026 showed A$249 to A$389 for one pen.

Wegovy pen price in Australian dollars, private prescription, November 2026

0.25 mg$249 – $259

0.5 mg$259

1 mg$269

1.7 mg$389

2.4 mg$389

The first four months take four pens, because the dose moves up every four weeks: $249 – $259, $259, $269, then $389.

After that, 1.7 mg or 2.4 mg costs $389 every four weeks. Thirteen 2.4 mg pens come to $5,057 a year.

First pen$249 – $259Each pen at 2.4 mg$389Thirteen pens at 2.4 mg$5,057

That is one public price list. Your price can differ with the pharmacy, stock, how you get the prescription, and any consultation or delivery fee.

Mounjaro pens on the same private prescription run from $270 to $689.

To see every dose and what it costs in Australia

See the Wegovy dosing chart

Prices for each dose are in Wegovy cost in Australia.

PBS patient charges in 2026

When a medicine is on the PBS, you pay a set patient charge. From 1 January 2026, general patients pay up to A$25 and concession card holders pay A$7.70.

PBS patient charges and Safety Net thresholds from 1 January 2026

General patient chargeUp to A$25

Concession card chargeA$7.70

General Safety Net thresholdA$1,748.20

Concession Safety Net thresholdA$277.20

These charges apply only to PBS-listed medicines. They do not apply to Wegovy today.

Ozempic, which has the same ingredient, is on the PBS for people with type 2 diabetes under a streamlined authority. It is not subsidised for weight loss alone.

Wegovy NovoCare

NovoCare is the patient programme Novo Nordisk runs in the US, and its Wegovy offer is for US prescriptions.

For Australia, use the private prices above as your guide. The US terms are on Wegovy coupon and savings card in the US.

How to get Wegovy at the lowest price you can

1Get a prescriptionAn Australian-registered prescriber writes it after a live consultation by video, phone or in person.

2Compare pharmacy pricesAsk two or three pharmacies for the same dose, with any consultation or delivery fee included.

3Watch the PBS status pageIf Wegovy is listed, ask your prescriber whether you meet the listing rules.

Your prescriber decides when to move up a dose.

To compare other drugs, see Mounjaro cost in Australia and Ozempic cost in Australia.

Wegovy PBS FAQ

Is Wegovy on the PBS in Australia?

No. As of 20 November 2026, Wegovy for weight loss is not on the PBS. The PBAC recommended it, but the listing has not occurred.

When will Wegovy be on the PBS?

There is no date yet. The PBS status page shows that agreement on listing terms and government processes have not commenced.

How much does Wegovy cost per month in Australia?

A$249 to A$389. That is $249 – $259 for 0.25 mg, $259 for 0.5 mg, $269 for 1 mg, and $389 for 1.7 mg and 2.4 mg.

Does Medicare cover Wegovy?

No. Wegovy is not on the PBS, so your Medicare card does not lower the price of the pen. It can apply to the consultation.

Does the PBS pay for Ozempic for weight loss?

No. The PBS lists Ozempic for type 2 diabetes only.

Can I use NovoCare in Australia?

No. NovoCare is a US programme for US prescriptions.

Keep reading

Wegovy cost in Australia: price by dose

Wegovy dosing chart: week by week

Mounjaro on the PBS in Australia

Ozempic on the PBS: who qualifies

What Wegovy is and how it works

Is there a generic Wegovy

GLP1 Note rechecks the PBS status and prices on this page every month against the PBS and PBAC pages. It is updated as soon as a listing happens. See how we check prices.

Update log

: First published.

Sources

Pharmaceutical Benefits Scheme, Medicine status: Wegovy (semaglutide), established cardiovascular disease with obesity.

Pharmaceutical Benefits Scheme, PBAC advice on equitable access to GLP-1 obesity treatments.

Pharmaceutical Benefits Scheme, Current patient fees and charges.

Pharmaceutical Benefits Scheme, PBS item 14846J, Ozempic (semaglutide) injection.

GLP1 Note is an independent information site and does not sell medicines. Prices and listing status can change, so check the PBS page before you rely on them.